Crinecerfont allows for significant glucocorticoid dose reductions in adults with classic CAH while maintaining androgen control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results